Director of Intellectual Property

Darum lohnt es sich

Acts as primary IP contact for Technical Operations in respect of Albumin, Fractionation + Horizon 2 and local nominated Integrated Product Teams (IPTs) such as Ig/Inframarginals, Recombinants and Iron.

The role will also serve as the IP advisor to selected European-based Research functions, including Drug Discovery, Translational Data Science, Non-Clinical Development and associated project teams. /p /lilipManage prosecution and defense of CSL intellectual property by supporting projects from early drug discovery to launch and beyond, including creating and safeguarding of a patent portfolio tailored to CSL’s activities with respect to pending applications and granted patents considering national and international laws and guidelines. /p /lilipContributes to the delivery of enterprise-wide IP strategy for new and existing development-stage products, including optimizing and defending regulatory exclusivities and lifecycle management activities. /p /lilipDrive strategic patent filings for key Swiss-owned products (e.g.

Privigen, Alburx) to maximise Swiss Patent Box benefits. /p /lilipPartner with European-based Research leadership to develop and implement IP strategies supporting pre-clinical programs, platform technologies and translational research activities across key therapeutic areas including Haematology, Cardiovascular Renal, and Transplant Immunology, Vaccines and Immunoglobulins. /p /lilipContribute to the identification and preservation of Trade Secrets and, in conjunction with IP team, ensure trade secrets are well protected within the Global IP strategy alongside other IP rights. /p /lilipLead invention harvesting, patent filing and portfolio development activities arising from Research and Technical Operations initiatives, including core technology platforms, manufacturing innovations, analytical methods, formulations, product improvements and next-generation product opportunities. /p /lilipProvide freedom to operate analysis across elected countries for assigned portfolio related risks, developing risk mitigation strategies and options and communicating to management and stakeholders. /p /lilipPartner with Technical Operations and Research as part of due diligence and deal opportunities. /p /lilipParticipation in the negotiation of agreements involving patent and related intellectual property matters, such as, confidential disclosures, material transfer, request for proposal (RFP), licensing agreements and other related matters. /p /lilipActively contributes to development of and delivery of education sessions to business partners on aspects of IP across the CSL enterprise. /p /lilipRepresent CSL Group directly or in cooperation with external attorneys. /p /lilipOther complex tasks within the Intellectual Property function as assigned including contributing to budget management. /p /lilipKey Relationships (internal and external) /ppIP team, including Head of IP and IP Leadership Team (IPLT) members. /ppTechnical Operations and European Research leadership where required. /ppIntegrated Product Teams (IPTs), where required. /ppResearch Project Teams (RPTs), where required. /ppRD Search / Strategy / Business Development, Procurement where required. /ppCSL Legal. /p /lipbEducation: /b /plipBachelor’s degree in life sciences discipline (chemistry, biochemistry, biotechnology) or a related field. /p /lilipMaster’s degree or PhD highly regarded. /p /lilipQualified Patent Attorney or IP lawyer admitted to practice in at least one jurisdiction (AU, CH, EP, DE, UK, US preferred) or equivalent legal qualifications and experience in Intellectual Property. /p /lipbExperience: /b /plipAt least 10 years post-qualification experience in Intellectual Property. /p /lilipExperience with life science technologies and operations of in-house IP teams with a background in a technical field relevant to CSL. /p /lilipExperience supporting biopharmaceutical research and development programs, including early research, translational science, non-clinical development or related innovation activities preferred. /p /lilipPatent management experience in an RD drug development environment preferred. /p /lilipExperience with agreements involving patent and related intellectual property matters. /p /lipThis is a hybrid role requiring 3 days per week of onsite presence. /pppbbAbout CSL Behring /b /b /p /ppCSL Behring is a global biotherapeutics leader driven by our promise to save lives.

Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. /ppTo learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at . /ppbOur Benefits /b /p pThe Director of Intellectual Property provides strategic support to CSL Research and Technical Operations organizations, with a primary responsibility for Tech Ops activities in Bern and Research in Schlieren (Zurich).

In particular, the role will support CSL plasma and recombinant platforms within Technical Operations and Translational Research activities. /ppThe Director of IP is responsible for identifying, protecting, managing, patent, trade secrets, exclusivities of all types and related intellectual property (IP) matters.

Additionally, the Director of IP assesses patentability of inventions, potential infringement of patents and exclusivities, agreements involving patents, know-how, trade secrets and other exclusivity rights, and management of third-party IP risk.

The position will work with some independence within the Global IP matrix work model to prepare, prosecute, maintain applications for the global patent portfolio, defend and enforce IP rights and partner with stakeholders and other CSL functions to maximize the value of IP for CSL. /ppbResponsibilities /b /plipManage and deliver global patent and related intellectual property strategies and support for significant portion of CSL Group’s global activities, especially relevant to CSL Research and Technical Operations.

Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.

We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. /ppbr/CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma.